[HTML][HTML] Lysosomal storage disease overview

A Sun - Annals of translational medicine, 2018 - ncbi.nlm.nih.gov
The lysosomal storage diseases (LSDs) are a group of inherited metabolic disorders that are
caused for the most part by enzyme deficiencies within the lysosome resulting in …

Gaucher disease: pathological mechanisms and modern management

M Jmoudiak, AH Futerman - British journal of haematology, 2005 - Wiley Online Library
Gaucher disease, the most common lysosomal storage disorder, is caused by the defective
activity of the lysosomal enzyme, acid‐β‐glucosidase (GlcCerase), leading to accumulation …

[HTML][HTML] Gaucher disease

GM Pastores, DA Hughes - 2018 - europepmc.org
Gaucher disease (GD) encompasses a continuum of clinical findings from a perinatal lethal
disorder to an asymptomatic type. The identification of three major clinical types (1, 2, and 3) …

Gaucher disease types 1 and 3: Phenotypic characterization of large populations from the ICGG Gaucher Registry

GA Grabowski, A Zimran, H Ida - American journal of …, 2015 - Wiley Online Library
Study of the natural history of Gaucher disease has revealed marked phenotypic variation.
Correlations to genotypes could provide insight into individual susceptibility to varying …

[HTML][HTML] The diagnosis and management of Gaucher disease in pediatric patients: Where do we go from here?

NJ Weinreb, O Goker-Alpan, PS Kishnani… - Molecular genetics and …, 2022 - Elsevier
Gaucher disease (GD) is an autosomal recessive inherited lysosomal storage disease that
often presents in early childhood and is associated with damage to multiple organ systems …

The clinical and demographic characteristics of nonneuronopathic Gaucher disease in 887 children at diagnosis

P Kaplan, HC Andersson, KA Kacena… - Archives of pediatrics & …, 2006 - jamanetwork.com
Objective To describe the clinical and demographic characteristics of nonneuronopathic
Gaucher disease (GD) in children at the time of diagnosis. Design Longitudinal …

The MPS I registry: design, methodology, and early findings of a global disease registry for monitoring patients with Mucopolysaccharidosis Type I

GM Pastores, P Arn, M Beck, JTR Clarke… - Molecular genetics and …, 2007 - Elsevier
A global, observational disease registry has been established to characterize the course of
disease and track clinical outcomes in patients with Mucopolysaccharidosis Type I (MPS I), a …

Revised recommendations for the management of Gaucher disease in children

P Kaplan, H Baris, L De Meirleir, M Di Rocco… - European journal of …, 2013 - Springer
Gaucher disease is an inherited pan-ethnic disorder that commonly begins in childhood and
is caused by deficient activity of the lysosomal enzyme glucocerebrosidase. Two major …

[HTML][HTML] Clinical manifestations and management of Gaucher disease

S Linari, G Castaman - Clinical Cases in Mineral and Bone …, 2015 - ncbi.nlm.nih.gov
Gaucher disease is a rare multi-systemic metabolic disorder caused by the inherited
deficiency of the lysosomal enzyme β-glucocerebrosidase, which leads to the accumulation …

Drug delivery product and methods

GR Ostroff - US Patent 7,740,861, 2010 - Google Patents
5,622,940 A 4, 1997 Ostroff The present invention provides a particulate delivery system
5,633,369 A 5, 1997 Jamas et al. comprising an extracted yeast cell wall comprising beta …